375 related articles for article (PubMed ID: 4595320)
1. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
2. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
Peter HH; Deutschmann EM; Schultheis W; Deicher H
Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
[TBL] [Abstract][Full Text] [Related]
3. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
Gutterman JU; Mavligit G; McBride C; Frei E; Hersh EM
Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
[No Abstract] [Full Text] [Related]
4. Treatment of malignant melanoma by intratumoral injection of BCG.
Pinsky CM; Hirshaut Y; Oettgen HF
Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
[No Abstract] [Full Text] [Related]
5. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
6. Intralesional BCG application in malignant melanoma.
Sopková B; Kolár V
Neoplasma; 1976; 23(4):421-6. PubMed ID: 794745
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in malignant melanomaa.
Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
[TBL] [Abstract][Full Text] [Related]
8. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
Wile AG; Sparks FC; Morton DL
Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
[TBL] [Abstract][Full Text] [Related]
9. BCG and cancer.
Bast RC; Zbar B; Borsos T; Rapp HJ
N Engl J Med; 1974 Jun; 290(26):1458-69. PubMed ID: 4598691
[No Abstract] [Full Text] [Related]
10. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy of malignant melanoma].
Adler A
Harefuah; 1986 Jul; 111(1-2):11-7. PubMed ID: 3781371
[No Abstract] [Full Text] [Related]
12. Mumps virus and BCG vaccine in metastatic melanoma.
Minton JP
Arch Surg; 1973 Apr; 106(4):503-6. PubMed ID: 4572347
[No Abstract] [Full Text] [Related]
13. Results of adjuvant BCG immunotherapy in malignant melanoma.
Wätzig V; Knopf B
Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442
[TBL] [Abstract][Full Text] [Related]
14. [Immunological aspects of melanoma].
Sjögren H
Lakartidningen; 1976 Feb; 73(7):528-30. PubMed ID: 1250045
[No Abstract] [Full Text] [Related]
15. [Cancer immunotherapy in dermatological view (author's transl)].
Lübbe D; Gstöttner R
Arch Geschwulstforsch; 1980; 50(2):182-5. PubMed ID: 7436703
[TBL] [Abstract][Full Text] [Related]
16. [Intranodular treatment with BCG of cutaneous and subcutaneous metastases of malignant melanoma (author's transl)].
Balzarini GP; Cascinelli N; Fontana V; Veronesi U
Tumori; 1974; 60(4):345-52. PubMed ID: 4439501
[No Abstract] [Full Text] [Related]
17. [BCG-treatment of malignant melanoma].
Borberg H
Internist (Berl); 1975 Oct; 16(10):482-5. PubMed ID: 1107254
[No Abstract] [Full Text] [Related]
18. [Immunotherapy of malignant melanomas].
Macher E
Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638
[No Abstract] [Full Text] [Related]
19. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
20. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
MacGregor AB; Falk RE; Landi S; Ambus U; Langer B
Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
